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Helicobacter pylori W Gastritis W Peyer’s patches W
ELAM-1 W ICAM-1 W TNF-·
Introduction
Historically surgical research has dealt mostly with
techniques to improve surgery on e.g. operation on the
open heart, organ transplantation, minimal invasive sur-
gery and peri- and postoperative pathophysiology. In this
regard there were fruitful research activities in the field of
sepsis, microcirculation, neurotrauma or the develop-
ment of lithotripsy of kidney and gallstones [1–6]. This
research has mostly been performed in model systems
including animal experiments.
The availability of new techniques in molecular biolo-
gy has boosted the research in a way that now samples
routinely taken from patients for diagnositic purposes can
be used to be analysed by these methods and bring further
insights into the pathology/pathophysiology of the dis-
eases. This can be illustrated by the analysis of relevant
expressed genes within the course of H. pylori related gas-
tritis where data from basic immunology of the GI-tract
can be illustrated in a relevant human disease.
The understanding of the regulation of an immune
response in the gut is of interest for many different dis-
eases. The hyperreactivity to food components like in coe-
liac disease and food allergy or the autoimmune reaction
in chronic inflammatory bowel disease may illustrate this.
On the other hand the induction of oral tolerance or the
understanding why bacteria can not only colonize the
intestine but also can induce severe infections and eventu-
ally transmigrate and end in a septic syndrome in e.g.
immunocompromized patients are all interesting ques-
tions which could be answered by a better understanding
of the mucosal immune system. In the investigation of GI
immunology surgical models gave new insights into the
function of Peyer’patches for the organisation of the local
immune system in the intestine. Using traditional tech-
niques of removing the patches it became clear that effec-
tor cells in the Peyer’s patches like M-cells (fig. 1) are
important players for initializing the immune response.
After reaching contact with luminally presented antigens,
they transfer this information to immune cells in the
patches which migrate to the mesenteric lymph nodes
where the local immune response becomes organized end-
ing with the spread of effector cells into the lamina pro-
pria and the intraepithelial space of the small intestine
[7–9]. This theory is now well appreciated and finds fur-
ther support with the notion that the transfer of the prion
protein form BSE might find its way by this pathway [10].
The organisation of the immune system of the stomach on
the other hand is not as well defined. There are usually no
lymph follicles resembling the Peyer’s patches and by
morphology no antigen presenting cells like M-cells in the
epithelial layer despite reports on the function of epithe-
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Fig. 1. Scanning electron microscopy of the epithelium covering a
Peyer’ patch of the rat. Two M-cells are clearly visible in the middle
characterized by the microfolds (!3,600).
Fig. 2. Analysis of IL-8 expression in biopsy specimen by RT-PCR.
Lane 1–4 are from controls, lanes 5–9 from H. pylori associated gas-
tritis. H = Stimulated HUVEC as positive control, M = molecular
weight marker. Fragment size on a 1% agarose gel is 255 bp. Amplifi-
cation was for 35 cycles.
lial cells as antigen presenting cells in other parts of the
intestine [11–13]. There are early reports on the induction
of an immune response in the stomach resulting in a hor-
mone response as well as in hypersensitivity [14–16]. A
more challenging view on the organization of the immune
system in the stomach came with the observation that a
bacterium is the causative agent in the induction of type B
gastritis, ulcer disease and eventually cancer. Helicobacter
pylori has been recognized to be responsible for these dis-
ease [17, 18]. So the question arises on the colonization
and the regulation of the local immune response with spe-
cial reference to how a protective immune response might
be inducible.
There is little known about how H. pylori initially over-
comes host defence and persists in a hostile environment.
The fact that many patients who harbour the bacterium
remain asymptomatic without developing manifest dis-
ease made it a model for investigating the time course and
severity of the immune response in the stomach as well as
for studying strain differences of the bacterium. The pow-
er of molecular biologic methods made it possible to gain
insight on sequential gene expression by means of analys-
ing the amount of specific RNA expressed in biopsies tak-
en from patients by e.g. RT-PCR. One or two biopsy spec-
imens are usually enough for the analysis of up to 10 dif-
ferent genes including standardization for a housekeeping
gene. Using such methods genes activated during the
development of an inflammatory response as well as
immune regulation can be easily analysed during the
course of a disease.
Materials and Methods
Biopsies were taken from patients during diagnostic endoscopy.
Usually the equivalent of one biopsy was used to isolate total RNA.
After homogenization of the biopsy in lysis puffer the total RNA was
isolated by its selective binding to a silica-matrix in spin columns
(RNAeasy; Qiagen, Hilden, Germany). After elution RNA was pre-
cipitated and either stored at –70°C or used for reverse transcrip-
tion. The cDNA was prepared according to a standard protocol using
MMLV-reverse transcriptase (Gibco BRL; Paisley, Scotland).
The amplification of a particular target gene by PCR was per-
formed as described [19]. Specific primers were selected from known
sequences and extensively tested against a data bank (GenBank,
BLAST). PCR was quantified after different cycle numbers on ethid-
ium bromide stained agarose gels using a densitometer with a sophis-
ticated software and normalized for housekeeping genes.
Results and Discussion
Using this method it became clear that in the early
phase of the infection the contact of the bacterium with the
epithelial layer of the stomach induces severe chemokine
production which is able to attract granulocytes into the
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Fig. 3. ICAM-1 (CD54) expression on control (lanes 1–5 ) and H.
pylori associated gastritis (lanes 6–11). H = Stimulated HUVEC as
positive control, M = molecular weight marker. Fragment size is
238 bp. Amplification was for 30 cycles.
Fig. 4. TNF-· expression in biopsy specimen from control (lanes 1–
4) and H. pylori associated gastritis (lanes 5–9). M is the molecular
weight marker, C are stimulated macrophages as positive control.
Fragment size is 444 bp, amplification for 35 cycles.
Fig. 5. IL-1ß expression in biopsy specimen from control (lanes 1–4)
and H. pylori associated gastritis (lanes 5–9). M is the molecular
weight marker, C are LPS stimulated PBL as positive control. Frag-
ment size is 447 bp, amplification for 35 cycles.
site of inflammation. As shown in figure 2 abundant IL8
message could be detected in the biopsy of patients with
gastritis. So the presence of the bacterium in the stomach
seems to be a trigger for local chemokine expression. This
observation could also be extended to the more epithelial
cell specific chemokine ENA-78 as shown previously [20].
Attraction and activation of granulocytes can be induced
by these cytokines. This induction was dependent on the
adherence of the bacterium to epithelial cells as shown by
in vitro stimulation experiments using gastric cell lines
[21]. Now chemokines are able to attract granulocytes as
well as lymphocytes. For granulocytes to leave the vessel it
is important that surface receptors on the granulocytes
interact with adhesion molecules on the local endothelial
cells. This interaction has been shown to either induce
rolling of cells along the vessel wall or stick before emi-
grating out of the blood vessel. The former is mediated by
the interaction of CD62P on the vessel and its ligand
PSGL-1 or CD62P on the blood cells. Solid adherence on
the other hand is mediated by the interaction of integrins
on blood cells and CD54 ( ICAM-1) on the endothelial
wall. ICAM 1 (fig. 3) was found expressed in all biopsies
with H. pylori associated gastritis and controls. The ex-
pression could also be shown by immunohistochemistry
where higher expression was found in gastritis. As counter
receptor on migrating cells the ß-2 integrin CD11/18 hete-
rodimer is effective. In this regard we and others were able
to show that soluble H. pylori products had the ability to
induce the upregulation of CD11b on granulocytes [22].
Inducible adhesion molecules might be more effective
in the attraction of activated blood cells. Candidates are
CD62E and CD 106 (VCAM) as well as the early marker
CD62P are candidates. With the exception of CD62E all
of these molecules could be found upregulated on endo-
thelial cells in gastritis specimens [19]. Apart from the
other molecules studied VCAM was not only detected on
some endothelial cells but also on follicular dendritic cells
in lymph follicles which appear in the lamina propria
after H. pylori infection [23]. As CD62 E (ELAM-1) is
found in chronic inflammatory lesions of the bowel it was
surprising that it could not be detected in H. pylori associ-
ated gastritis since potent inducers for CD62E like IL1-ß
and TNF-· were detected in the same biopsies. Interest-
ingly, whereas TNF-· was induced (fig. 4) IL1-ß was con-
stitutively expressed in all samples (fig. 5). IL1-ß has been
shown to have dramatic effects on the acid output of the
stomach [24, 25]. This seems to suggest that acid produc-
tion could be regulated by a different pathway in health
and disease. On the other hand TNF-· is a potent inducer
of adhesion molecules on endothelial cells. So it may well
be that in the stomach adhesion molecule regulation dif-
fers from other parts of the intestine.
With the help of molecular biological methods it is now
possible to get data from routine biopsies which expand
the knowledge on the pathogenesis of a particular disease.
In this respect H. pylori induced gastritis serves as a para-
digm for an immune response in the stomach. Not only
can the local reaction of the patient be analysed and fol-
lowed after eradication but also reasons for recurrence of
the disease studied. In addition basic data on the immune
regulation in the stomach can be obtained. However, why
patients who are Helicobacter pylori infected vary in their
clinical presentation of manifest disease from being
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asymptomatic to developing gastric carcinoma remains a
baffling question. A broad variation in the genetic reper-
toire of the patient as well as of the bacterium may be the
answer. With the disclosure of the complete H. pylori
genome every variation and gene shift should be detect-
able [26]. Even the publication of the human genome
offers additional chances to evaluate differences in the
reaction of the immune system in the stomach wall.
So is this the end of H. pylori research in the stomach
with the description of the pathogenesis and the possibili-
ty to eradicate the bug? Eradication studies have shown
that some changes in the pathology persist even after lon-
ger periods of time [27]. For example a possible increase
in Barrett carcinomas after eradication has been observed
[28–30]. So H. pylori infection may even have some bene-
ficial effects on some unknown defence mechanism as for
example acting protective on the gastro-oesophageal junc-
tion. These new aspects are open for investigations on the
genetic repertoire expressed by the bacterium as well as by
the particular patient. So the combination of a surgeon
having access to human tissues and a powerful lab using
molecular biological methods allows the investigation of
the pathophysiological events and offers new insights into
clinically relevant disease.
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